| # | Drug | Count |
|---|---|---|
| 0 | ISOTRETINOIN | 5253 |
| 1 | ADALIMUMAB | 786 |
| 2 | INFLIXIMAB | 553 |
| 3 | PREDNISONE | 463 |
| 4 | VEDOLIZUMAB | 371 |
| 5 | METHOTREXATE SODIUM | 368 |
| 6 | METHOTREXATE | 323 |
| 7 | ADALIMUMAB-ADAZ | 310 |
| 8 | ADALIMUMAB-AATY | 281 |
| 9 | ADALIMUMAB-FKJP | 279 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, EUCALYPTUS OIL AND MENTHOL | 1 | 0.5000 |
| 1 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 18 | 0.1111 |
| 2 | BENZOYL PEROXIDE 4% | 1 | 0.1111 |
| 3 | ISOTRETINOIN | 5253 | 0.1050 |
| 4 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 2 | 0.0247 |
| 5 | BENZOCAINE AND CHLOROXYLENOL | 1 | 0.0222 |
| 6 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 7 | OLSALAZINE SODIUM | 3 | 0.0152 |
| 8 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0143 |
| 9 | TAZAROTENE | 14 | 0.0118 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 5285 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1126 |
| 2 | Corticosteroid [EPC] | 766 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 625 |
| 4 | Interleukin-17A Antagonist [EPC] | 594 |
| 5 | Integrin Receptor Antagonist [EPC] | 381 |
| 6 | Interleukin-23 Antagonist [EPC] | 351 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 321 |
| 8 | Aminosalicylate [EPC] | 318 |
| 9 | Interleukin-12 Antagonist [EPC] | 263 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Retinoid [EPC] | 5285 | 0.0214 |
| 1 | Interleukin-17A Antagonist [EPC] | 594 | 0.0159 |
| 2 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 3 | Provitamin D2 Compound [EPC] | 165 | 0.0055 |
| 4 | Serotonin-4 Receptor Agonist [EPC] | 3 | 0.0046 |
| 5 | Integrin Receptor Antagonist [EPC] | 381 | 0.0044 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 7 | Tricyclic Antidepressant [EPC] | 2 | 0.0042 |
| 8 | Human Blood Coagulation Factor [EPC] | 3 | 0.0036 |
| 9 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |